athenahealth, Inc. (NASDAQ:ATHN)‘s stock had its “overweight” rating reiterated by investment analysts at Piper Jaffray Companies in a report issued on Friday. They currently have a $171.00 price objective on the health services provider’s stock. Piper Jaffray Companies’ target price points to a potential upside of 18.92% from the company’s current price. The analysts noted that the move was a valuation call.
Several other equities research analysts have also weighed in on ATHN. UBS AG set a $123.00 price objective on athenahealth and gave the stock a “buy” rating in a research note on Monday, May 1st. William Blair reissued a “market perform” rating on shares of athenahealth in a research note on Friday. BidaskClub lowered athenahealth from a “hold” rating to a “sell” rating in a research note on Wednesday, July 12th. Citigroup Inc. reissued a “buy” rating and set a $169.00 price objective (up from $163.00) on shares of athenahealth in a research note on Monday, July 10th. Finally, Argus began coverage on athenahealth in a research note on Friday, July 7th. They set a “hold” rating for the company. One research analyst has rated the stock with a sell rating, fourteen have given a hold rating and twelve have given a buy rating to the company. athenahealth currently has an average rating of “Hold” and an average target price of $141.90.
athenahealth (NASDAQ:ATHN) traded up 6.29% during trading on Friday, hitting $152.84. The stock had a trading volume of 1,395,260 shares. The firm’s 50-day moving average price is $141.51 and its 200-day moving average price is $122.62. The stock has a market cap of $6.09 billion, a PE ratio of 300.87 and a beta of 1.79. athenahealth has a 1-year low of $90.11 and a 1-year high of $158.66.
athenahealth (NASDAQ:ATHN) last released its quarterly earnings data on Thursday, July 20th. The health services provider reported $0.51 earnings per share for the quarter, topping the consensus estimate of $0.39 by $0.12. The business had revenue of $301.10 million during the quarter, compared to analyst estimates of $298.68 million. athenahealth had a return on equity of 5.93% and a net margin of 1.84%. The company’s revenue was up 15.0% compared to the same quarter last year. During the same period last year, the company posted $0.34 EPS. On average, equities research analysts predict that athenahealth will post $1.86 earnings per share for the current fiscal year.
COPYRIGHT VIOLATION NOTICE: This report was published by Sports Perspectives and is the sole property of of Sports Perspectives. If you are reading this report on another domain, it was copied illegally and republished in violation of U.S. and international copyright legislation. The legal version of this report can be read at https://sportsperspectives.com/2017/07/21/athenahealths-athn-overweight-rating-reiterated-at-piper-jaffray-companies.html.
In other athenahealth news, SVP Jonathan D. Porter sold 300 shares of the firm’s stock in a transaction dated Monday, July 17th. The stock was sold at an average price of $143.13, for a total transaction of $42,939.00. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, CEO Jonathan Bush sold 8,000 shares of the firm’s stock in a transaction dated Tuesday, April 25th. The shares were sold at an average price of $120.00, for a total value of $960,000.00. Following the transaction, the chief executive officer now owns 319,807 shares in the company, valued at $38,376,840. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 25,683 shares of company stock worth $3,329,871. Corporate insiders own 3.20% of the company’s stock.
A number of institutional investors have recently bought and sold shares of ATHN. FNY Partners Fund LP raised its position in athenahealth by 1,900.0% in the first quarter. FNY Partners Fund LP now owns 1,000 shares of the health services provider’s stock valued at $112,000 after buying an additional 950 shares during the period. Russell Investments Group Ltd. bought a new position in athenahealth during the fourth quarter valued at $118,000. Teza Capital Management LLC bought a new position in athenahealth during the first quarter valued at $220,000. Comerica Bank bought a new position in athenahealth during the fourth quarter valued at $299,000. Finally, Arxis Securities LLC bought a new position in athenahealth during the first quarter valued at $304,000.
athenahealth, Inc provides network-based medical record, revenue cycle, patient engagement, care coordination and population health services. The Company also offers Epocrates and other point-of-care mobile applications. The Company delivers majority of its service offerings through a single instance of cloud-based software, athenaNet.
Receive News & Ratings for athenahealth Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for athenahealth Inc. and related companies with MarketBeat.com's FREE daily email newsletter.